ClinicalTrials.Veeva

Menu

Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study (IDEAL-LDL)

A

AHEPA University Hospital

Status

Completed

Conditions

Acute Coronary Syndrome

Treatments

Behavioral: Motivational Interview

Study type

Interventional

Funder types

Other

Identifiers

NCT02927808
22904/25.5.2016

Details and patient eligibility

About

This study will investigate the impact of motivational interviewing in achieving low-density lipoprotein cholesterol therapeutic targets in patients with acute coronary syndromes.

Full description

To determine whether a strategy of enhanced information about the risks of high plasma low-density lipoprotein cholesterol (LDL-C) and the importance of lipid-lowering medication together with close follow-up and motivational interviewing is superior than usual care in achieving LDL-C therapeutic targets, as set by current practice guidelines (LDL-C <70 mg/dL or >50% reduction from baseline LDL-C) in patients with acute coronary syndromes.

Enrollment

360 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject hospitalized for acute coronary syndrome (STEMI, NTEMI or unstable angina)
  • Subject currently on lipid-lowering therapy or prescribed lipid-lowering therapy at hospital discharge (statins and/or other agents)
  • Subject who is 18 years or older
  • Subject or legally authorized representative who is willing and capable of providing informed consent, participating in all associated study activities

Exclusion criteria

  • Subject unable to communicate via telephone for study interviewing
  • Subject with contraindication to statin therapy
  • Subject with any medical disorder that would interfere with completion or evaluation of clinical study results

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

360 participants in 2 patient groups

Intervention group - Motivational Interview
Experimental group
Description:
Patients assigned to the intervention group will be given a leaflet entitled "Information leaflet about LDL Cholesterol" that will educate them about the risks of high LDL-C and the importance of adherence to lipid-lowering medication. Patients assigned to the intervention group will be contacted via telephone for a pre-specified interview (motivational interview again stressing the importance of adherence to lipid-lowering medication) at 1 month and 6 months after discharge, and for an in-person interview plus lipid profiling at 1 year after discharge.
Treatment:
Behavioral: Motivational Interview
Control group
No Intervention group
Description:
Patients assigned to the control group will be contacted for a pre-specified in-person interview plus lipid profiling at 1 year after discharge.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems